Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
1.250
-0.070 (-5.30%)
Dec 5, 2025, 4:00 PM EST - Market closed
Mustang Bio Market Cap
Mustang Bio has a market cap or net worth of $9.12 million as of December 5, 2025. Its market cap has decreased by -13.11% in one year.
Market Cap
9.12M
Enterprise Value
-9.86M
1-Year Change
-13.11%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since August 22, 2017, Mustang Bio's market cap has decreased from $257.00M to $9.12M, a decrease of -96.45%. That is a compound annual growth rate of -33.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 9.60M | 12.94% |
| Dec 31, 2024 | 8.50M | -31.45% |
| Dec 29, 2023 | 12.40M | -70.75% |
| Dec 30, 2022 | 42.40M | -72.66% |
| Dec 31, 2021 | 155.10M | -37.18% |
| Dec 31, 2020 | 246.90M | 49.18% |
| Dec 31, 2019 | 165.50M | 106.36% |
| Dec 31, 2018 | 80.20M | -74.50% |
| Dec 29, 2017 | 314.50M | 22.37% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |